Delivery Order SPE2DB24D1205-SPE2DB25FCVJZ
Award Date
3/31/25
Potential Completion Date
4/21/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medication, with a ceiling value of $13,953.30 and a performance period ending on May 21, 2025. This contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $6,976.65 and a performance period through May 2025. The contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,197.41, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,640.10, is a delivery order for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,953.30 firm fixed-price contract is for the delivery of 4567995177 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a performance period through May 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,197.41 firm fixed-price delivery order is for the supply of 4564977632 - LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a performance period ending on July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...
This federal contract award, valued at $9,302.20, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a performance period ending on May 28, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $2,197.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML syringes. The contract has a ceiling value of $6,592.23 and a period of performance through October 11, 2024. Amerisourcebergen, as the prime contractor, will be responsible for delivering these medical supplies to support military treatment facilities and other federal healthcare providers. The...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Department of Defense (DoD) Medical Supply Chain (VPDLATSMED-A). The contract is for $10,987.05 and provides the DoD with the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...